Browsing Medicina by Subject "Abrocitinib"
Now showing items 1-1 of 1
-
Article
Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study
(Wiley, 2024)Background Abrocitinib, a selective JAK 1 inhibitor, was recently approved in Europe. Despite its approval, real-world ...